[Treatment of purulent meningites in children].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002675:Child, Preschool; D004927:Escherichia coli Infections / Q000188:drug therapy; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007710:Klebsiella Infections / Q000188:drug therapy; D008581:Meningitis / Q000517:prevention & control / Q000628:therapy*; D008583:Meningitis, Haemophilus / Q000188:drug therapy; D008585:Meningitis, Meningococcal / Q000188:drug therapy; D008586:Meningitis, Pneumococcal / Q000188:drug therapy; D011512:Proteus Infections / Q000188:drug therapy; D011552:Pseudomonas Infections / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013449:Sulfonamides / Q000627:therapeutic use; D013492:Suppuration / Q000628:therapy
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D013449:Sulfonamides
Traitement des méningites purulentes de l'enfant.